A vaccine compensation scheme ought to be established as “a matter of urgency”, an expert group has told the Government.
According to the Irish Times, the group which is chaired by Mr Justice Charles Meenan, was set up in 2018 to examine alternative systems for dealing with clinical negligence claims arising from the CervicalCheck scandal.
The report, which was published on Wednesday, “accepts that there is a strong moral argument that the State, which actively encourages vaccination, should accept responsibility for those who suffer harm as a result”.
“There are also pragmatic reasons to support the establishment of a compensation scheme, namely: to maintain vaccination uptake rates, inspire confidence amongst the population and to maintain the supply of vaccines from manufacturers who may be concerned about liability and costs,” it continued.
The report added that the urgency with which the compensation scheme ought to be established “has been highlighted by recent publicity and public commentary concerning certain vaccines”.
Members of the expert group expressed different views as to what the appropriate level of compensation ought to be.
Ex gratia scheme
One view was that awards made by a compensation scheme should be in line with awards that would be made by a court.
A more widely held view was that the awards ought to be below the level of an award that would be made by a court where liability was established.
The reason for this was that an ex gratia scheme would relieve claimants of the heavy onus of having to prove liability, but at the same time they would not lose their entitlement to bring court proceedings.
“In order to be effective, the awards made by an ex gratia compensation scheme would have to be reasonable, based on proven loss,” it said.
Minister for Health Stephen Donnelly and Minister for Justice Helen McEntee have received the report and both will return to Government following further consideration of the recommendations proposed.
Earlier this week, Taoiseach Micheál Martin said both Ministers were working on a vaccine compensation scheme after he was challenged about the indemnity offered to pharmaceutical companies developing the Covid-19 vaccine.
He said the Cabinet agreed a compensation scheme would be developed after considering the Meenan report.
More generally, the expert group said it was “firmly” of the view that the current legal system “urgently requires reform”.
